Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/12219
Title: Dihydroartemisinin-piperaquine versus chloroquine in the treatment of plasmodium vivax malaria in Thailand: A randomized controlled trial
Authors: Aung Pyae Phyo
Khin Maung Lwin
Ric N. Price
Elizabeth A. Ashley
Bruce Russell
Kanlaya Sriprawat
Niklas Lindegardh
Pratap Singhasivanon
Nicholas J. White
François Nosten
Shoklo Malaria Research Unit
Mahidol University
Menzies School of Health Research
Nuffield Department of Clinical Medicine
Agency for Science, Technology and Research, Singapore
Keywords: Medicine
Issue Date: 15-Nov-2011
Citation: Clinical Infectious Diseases. Vol.53, No.10 (2011), 977-984
Abstract: Background. Chloroquine (CQ) remains the treatment of choice for Plasmodium vivax malaria. Initially confined to parts of Indonesia and Papua, resistance of P. vivax to CQ seems to be spreading, and alternative treatments are required. Methods. We conducted a randomized controlled study to compare the efficacy and the tolerability of CQ and dihydroartemisinin-piperaquine (DP) in 500 adults and children with acute vivax malaria on the Northwestern border of Thailand. Results. Both drugs were well tolerated. Fever and parasite clearance times were slower in the CQ than in the DP group (P < . 001). By day 28, recurrent infections had emerged in 18 of 207 CQ recipients compared with 5 of 230 treated with DP (relative risk, 4.0; 95% confidence interval [CI], 1.51-10.58; P =. 0046). The cumulative risk of recurrence with P. vivax at 9 weeks was 79.1% (95% CI, 73.5%-84.8%) in patients treated with CQ compared with 54.9% (95% CI, 48.2%-61.6%) in those receiving DP (hazard ratio [HR] , 2.27; 95% CI, 1.8-2.9; P < . 001). Children < 5 years old were at greater risk of recurrent P. vivax infection (74.4%; 95% CI, 63.2%-85.6%) than older patients (55.3% [95% CI, 50.2%-60.4%]; HR, 1.58 [95% CI, 1.1-2.2] ; P =. 005). In vitro susceptibility testing showed that 13% of the tested isolates had a CQ median inhibitory concentration > 100 nmol/L, suggesting reduced susceptibility. Conclusions. The efficacy of CQ in the treatment of P. vivax infections is declining on the Thai-Myanmar border. DP is an effective alternative treatment. © 2011 The Author Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=80054767617&origin=inward
http://repository.li.mahidol.ac.th/dspace/handle/123456789/12219
ISSN: 15376591
10584838
Appears in Collections:Scopus 2011-2015

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.